29 Results for "

Parietal cells

" in MedChemExpress (MCE) Product Catalog:
Products (29)

29 Results for "Parietal cells" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-15498
CAS No.: 1289023-67-1
Purity:  99.94%
Synonyms: BMS-927711; BHV-3000
Target:  

CGRP Receptor

Research Areas:  

Neurological Disease

Rimegepant (BMS-927711; BHV-3000) is an orally bioavailable and blood-brain barrier permeable antagonist of CGRP and AMY1 receptors, with a pIC50 of 8.01 and a Ki of 0.027 nM for human CGRP receptors. Rimegepant antagonizes cAMP production induced by αCGRP, βCGRP and amylin at CGRP and AMY1 receptors in humans, rats and mice, as well as at rat AMY3 receptors. Rimegepant can be used in research related to migraine .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-17021
CAS No.: 119141-88-7
Synonyms: (S)-Omeprazole; (-)-Omeprazole
Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-17023
CAS No.: 161796-78-7
Synonyms: (S)-Omeprazole sodium; (-)-Omeprazole sodium
Research Areas:  

Endocrinology Cancer

Esomeprazole sodium ((S)-Omeprazole sodium) is a potent and orally active proton pump inhibitor. Esomeprazole reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole acts as an exosome inhibitor by blocking the exosome release via the inhibition of V-H +-ATPases . Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-17021B
CAS No.: 161796-84-5
Synonyms: (S)-Omeprazole potassium salt; (-)-Omeprazole potassium salt
Esomeprazole potassium salt ((S)-Omeprazole potassium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole potassium salt has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-101664
CAS No.: 172152-36-2
Purity:  99.97%
Synonyms: IY-81149
Target:  

Proton Pump TOPK

Research Areas:  

Inflammation/Immunology Cancer

Ilaprazole (IY-81149) is an orally active proton pump inhibitor. Ilaprazole irreversibly inhibits H +/K +-ATPase in a dose-dependent manner with an IC50 of pump inhibitory activity of 6 μM in rabbit parietal cell preparation. Ilaprazole is used for the research of gastric ulcers. Ilaprazole is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor .
loading...
    loading...
Cat. No.: HY-115822
CAS No.: 81839-27-2
Purity:  ≥99.0%
α-Fluoromethylhistidine dihydrochloride is an orally active histidine decarboxylase inhibitor. α-Fluoromethylhistidine dihydrochloride depletes histamine in enterochromaffin-like (ECL) cells, reduces the number and volume density of secretory vesicles in ECL cells, and does not affect histamine storage in mast cells. α-Fluoromethylhistidine dihydrochloride abolishes Omeprazole (HY-B0113)-induced vacuolization of ECL cells and decreases gastrin-induced histamine efflux from ECL cells. α-Fluoromethylhistidine dihydrochloride does not alter the granular characteristics of ECL cells, omeprazole-induced hypertrophy of ECL cells, gastrin-induced pancreastatin-like immunoreactivity efflux, nor does it affect gastric acid secretion induced by histamine or vagal stimulation. α-Fluoromethylhistidine dihydrochloride inhibits basal and gastrin-stimulated gastric acid secretion, reduces acid output induced by gastrin+IBMX (HY-12318), but does not directly affect acid generation in isolated parietal cells .
loading...
    loading...
Cat. No.: HY-B2145
CAS No.: 172152-50-0
Synonyms: IY-81149 sodium
Target:  

Proton Pump TOPK

Research Areas:  

Inflammation/Immunology Cancer

Ilaprazole (IY-81149) sodium is an orally active proton pump inhibitor. Ilaprazole sodium irreversibly inhibits H +/K +-ATPase in a dose-dependent manner with an IC50 of 6 μM in rabbit parietal cell preparation. Ilaprazole sodium is used for the research of gastric ulcers. Ilaprazole sodium is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor .
loading...
    loading...
Cat. No.: HY-P5815
CAS No.: 99658-04-5
Synonyms: Glucagon-like Peptide 1 (1-36) amide (human, rat)
Target:  

GLP Receptor GCGR

Research Areas:  

Metabolic Disease

GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. GLP-1 (1-36) amide (human, rat) can stimulate [14C]aminopyrine accumulation on enzymatically dispersed enriched rat parietal cells .
loading...
    loading...
Cat. No.: HY-P5815A
Synonyms: Glucagon-like Peptide 1 (1-36) amide (human, rat) TFA
Target:  

GLP Receptor GCGR

Research Areas:  

Metabolic Disease

GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) TFA is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. GLP-1 (1-36) amide (human, rat) TFA can stimulate [14C]aminopyrine accumulation on enzymatically dispersed enriched rat parietal cells .
loading...
    loading...
Cat. No.: HY-W1015419
CAS No.: 73804-75-8
Synonyms: α-Fluoromethylhistidine
α-FMH (α-Fluoromethylhistidine) is an orally active histidine decarboxylase inhibitor. α-FMH depletes histamine in enterochromaffin-like (ECL) cells, reduces the number and volume density of secretory vesicles in ECL cells, and does not affect histamine storage in mast cells. α-FMH abolishes Omeprazole (HY-B0113)-induced vacuolization of ECL cells and decreases gastrin-induced histamine efflux from ECL cells. α-FMH does not alter the granular characteristics of ECL cells, omeprazole-induced hypertrophy of ECL cells, gastrin-induced pancreastatin-like immunoreactivity efflux, nor does it affect gastric acid secretion induced by histamine or vagal stimulation. α-FMH inhibits basal and gastrin-stimulated gastric acid secretion, reduces acid output induced by gastrin+IBMX (HY-12318), but does not directly affect acid generation in isolated parietal cells .
loading...
    loading...
Cat. No.: HY-17021A
CAS No.: 1198768-91-0
Synonyms: (S)-Omeprazole magnesium salt; (-)-Omeprazole magnesium salt
Esomeprazole magnesium salt ((S)-Omeprazole magnesium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole magnesium salt has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-17021S1
Synonyms: (S)-Omeprazole-d3; (-)-Omeprazole-d3
Esomeprazole-d3 is deuterium labeled Esomeprazole. Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-17021R
CAS No.: 119141-88-7
Synonyms: (S)-Omeprazole (Standard); (-)-Omeprazole (Standard)
Esomeprazole (Standard) is the analytical standard of Esomeprazole. This product is intended for research and analytical applications. Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-19105A
CAS No.: 126463-66-9
Target:  

Histamine Receptor

Research Areas:  

Inflammation/Immunology

IT 066 hydrochloride is a Histamine H2 receptor antagonist. IT 066 hydrochloride possesses antioxidant activity and can protect rats against acute gastric mucosal injury induced by ischemia-reperfusion. IT 066 hydrochloride can also inhibit secretagogue-induced gastric acid secretion in rats and exert a long-acting anti-lesion effect on experimental gastric and duodenal lesions in rats. IT 066 hydrochloride is applicable for the research of gastrointestinal diseases .
loading...
    loading...
Cat. No.: HY-17023R
CAS No.: 161796-78-7
Synonyms: (S)-Omeprazole sodium (Standard); (-)-Omeprazole sodium (Standard)
Esomeprazole (sodium) (Standard) is the analytical standard of Esomeprazole (sodium). This product is intended for research and analytical applications. Esomeprazole sodium ((S)-Omeprazole sodium) is a potent and orally active proton pump inhibitor. Esomeprazole reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole acts as an exosome inhibitor by blocking the exosome release via the inhibition of V-H +-ATPases . Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-19106
CAS No.: 132197-26-3
Target:  

Secretin Receptor

MCI-727 free base is an orally active anti-ulcer agent. MCI-727 free base can increase the plasma secretin concentration in rats and dogs. MCI-727 free base can also stimulate the exocrine function of the pancreas in rats by promoting the release of endogenous secretin, and exert preventive and therapeutic effects on mild acute pancreatitis. MCI-727 free base can be used in the research of ulcer-related diseases .
loading...
    loading...
Cat. No.: HY-121977
CAS No.: 199335-15-4
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

IKs124 is KCNE2/KCNQ1 potassium channel blocker with the with an IC50 of 8 nM. IKs124 can be used for study of peptic ulcers .
loading...
    loading...
Cat. No.: HY-17023S
CAS No.: 922731-04-2
Synonyms: (S)-Omeprazole-d6 sodium; (-)-Omeprazole-d6 sodium
Esomeprazole-d6 sodium is the deuterium labeled Esomeprazole. Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-17021C
CAS No.: 914613-86-8
Synonyms: (S)-Omeprazole hemistrontium; (-)-Omeprazole hemistrontium
Esomeprazole ((S)-Omeprazole) hemistrontium is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H +, K +-ATPase in gastric parietal cells. Esomeprazole hemistrontium has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...
Cat. No.: HY-17021S
Synonyms: (S)-Omeprazole-d3 sodium; (-)-Omeprazole-d3 sodium
Esomeprazole-d3 (sodium) is the deuterium labeled Esomeprazole. Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .
loading...
    loading...